BackDeep Medicine Acquisition Overview

Deep Medicine Acquisition Total Liabilities

Track Deep Medicine Acquisition's total liabilities ($17M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$17.09M
32.39% YoYΔ $-8.19M vs prior year quarter

Peer average

Loading

Deep Medicine Acquisition Total Liabilities History

Loading

Deep Medicine Acquisition vs. peers: Total Liabilities Comparison

Loading

Deep Medicine Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deep Medicine Acquisition (DMAQ) FAQ

As of the most recent data (March 2026), DMAQ shows a total liabilities of $17M. That compares with $25M in the prior-year period — down 32.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAQ's total liabilities is now $17M (was $25M) — a 32.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition is outperforming or lagging.

Tracking DMAQ's total liabilities over time shows whether Deep Medicine Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $17M That compares with $25M in the prior-year period — down 32.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Deep Medicine Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $17M) with ownership activity and broader fundamentals.